About Igenetic
Igenetic is a company based in Mumbai (India) founded in 2013 by Siddharth Patodia. Igenetic has raised $24.04 million across 4 funding rounds from investors including Manipal Group, British International Investment and Thomas C Barry. The company has 241 employees as of April 08, 2024. Igenetic operates in a competitive market with competitors including Thyrocare, Vijaya Diagnostic Centre, Suraksha Diagnostics, Krsnaa Diagnostics and Medall, among others.
- Headquarter Mumbai, India
- Employees 241 as on 08 Apr, 2024
- Founders Siddharth Patodia
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Igenetic Diagnostics Private Limited
- Date of Incorporation 12 Dec, 2013
- Jurisdiction Banglore, Karnataka, India
-
Annual Revenue
$6.4 M (USD)92.15as on Mar 31, 2021
-
Net Profit
$47.59 K (USD)102.84as on Mar 31, 2021
-
EBITDA
$242.25 K (USD)116.43as on Mar 31, 2021
-
Total Equity Funding
$24.04 M (USD)
in 4 rounds
-
Latest Funding Round
$1.22 M (USD), Series A
Jan 23, 2020
-
Investors
Manipal Group
& 35 more
-
Employee Count
241
as on Apr 08, 2024
-
Acquired by
(Oct 22, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Igenetic
Igenetic has successfully raised a total of $24.04M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.22 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Igenetic
Igenetic has secured backing from 36 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include Manipal Group, British International Investment and Thomas C Barry.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency focused on small and medium-sized businesses
|
Locked | Locked | Locked | |
|
High-growth businesses are targeted for investment by SFG Ventures.
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Igenetic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Igenetic
Investment portfolio details for Igenetic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Igenetic
Detailed financials for Igenetic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Igenetic Comparisons
Peer comparison for Igenetic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Igenetic
Igenetic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Thyrocare, Vijaya Diagnostic Centre, Suraksha Diagnostics, Krsnaa Diagnostics and Medall, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic testing centers for pathology and health screenings are operated.
|
|
| Locked | Locked | Locked |
Diagnostic services are offered via a chain of centers.
|
|
| Locked | Locked | Locked |
Pathology, molecular diagnostics, and imaging services are provided.
|
|
| Locked | Locked | Locked |
Chain of radiology & pathology laboratory centers
|
|
| Locked | Locked | Locked |
Medical diagnostic services are provided through a chain of centres.
|
Detailed competitors of Igenetic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Igenetic
Complete news archive for Igenetic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Igenetic
Igenetic was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Igenetic is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Igenetic is a funded company, having raised a total of $24.04M across 4 funding rounds to date.
As of Apr 08, 2024, the latest employee count at Igenetic is 241.
Annual revenue of Igenetic is $6.4M as on Mar 31, 2021.
Igenetic was founded in 2013 in Mumbai, India, and operates in the molecular diagnostics sector. Tests for genetic analysis in oncology, neurology, and infectious diseases are offered by the company. In-house development of tests and products is also supported through its capabilities. Services focus on healthcare applications across these medical fields.
Igenetic's top competitors include Thyrocare, Krsnaa Diagnostics and Suraksha Diagnostics.
Igenetic has 36 investors. Key investors include Manipal Group, British International Investment, Thomas C Barry, Mahesh Chhabria, and Pratik Jain.
The valuation of Igenetic is $21.44M as of Jan 2020.